Merck & Co., Inc. vs Johnson & Johnson
MRK vs JNJ — side-by-side comparison from reported financials. MRK leads 2, JNJ leads 9 of 11 comparable metrics.
Merck & Co., Inc.
MRK · Healthcare
$146.33+2.77%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | MRK | JNJ |
|---|---|---|
| Price | $146.33 | $261.79 |
| Market cap | $361B | $631B |
| Revenue (TTM) | $66.6B | $97.9B |
| Revenue growth | +3.1% | +5.6% |
| Net margin | 4.8% | 21.5% |
| Free cash flow | $16.1B | $22.2B |
| Net cash (debt) | ($34.8B) | ($27.8B) |
| 1-year price return | +67.2% | +37.0% |
| P/E | 113.2 | 29.9 |
| P/E vs own history (cheap-side %) | 7% | 16% |
| Dividend yield | 2.31% | 2.00% |
| Return on equity | 7% | 26% |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 75,000 | 140,800 |
Full résumé-style profiles: MRK CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.